speb/financial-data huggingface dataset:
CLST cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -314000.00
CLST cash_flow (annual, 2022-12-31) — Change In Working Capital: -639000.00
CLST cash_flow (annual, 2022-12-31) — Changes In Cash: -27412000.00
CLST balance_sheet (annual, 2022-12-31) — Common Stock: 53000.00
CLST balance_sheet (annual, 2022-12-31) — Common Stock Equity: 88512000.00
CLST cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CLST cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CLST balance_sheet (annual, 2022-12-31) — Construction In Progress: 0.00
CLST cash_flow (annual, 2022-12-31) — Deferred Income Tax: -9000.00
CLST cash_flow (annual, 2022-12-31) — Deferred Tax: -9000.00
CLST cash_flow (annual, 2022-12-31) — Depreciation: 448000.00
CLST cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 448000.00
CLST cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 448000.00
CLST income_statement (annual, 2022-12-31) — Diluted Average Shares: 4500000.00
CLST income_statement (annual, 2022-12-31) — Diluted EPS: 0.04
CLST income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 180000.00
CLST cash_flow (annual, 2022-12-31) — End Cash Position: 13472000.00
CLST cash_flow (annual, 2022-12-31) — Financing Cash Flow: -14041000.00
CLST cash_flow (annual, 2022-12-31) — Free Cash Flow: 520000.00
CLST cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 77000.00
CLST income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 0.00
CLST balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -9074000.00
CLST income_statement (annual, 2022-12-31) — General And Administrative Expense: 5259000.00
CLST balance_sheet (annual, 2022-12-31) — Gross PPE: 9718000.00
CLST balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 13475000.00
CLST cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 243000.00
CLST income_statement (annual, 2022-12-31) — Insurance And Claims: 135000.00
CLST income_statement (annual, 2022-12-31) — Interest Expense: 683000.00
CLST income_statement (annual, 2022-12-31) — Interest Income: 8014000.00
CLST cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 496000.00
CLST cash_flow (annual, 2022-12-31) — Investing Cash Flow: -14143000.00
CLST balance_sheet (annual, 2022-12-31) — Investments And Advances: 93077000.00
CLST cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CLST cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CLST balance_sheet (annual, 2022-12-31) — Land And Improvements: 1767000.00
CLST cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CLST balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1743000.00
CLST cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CLST income_statement (annual, 2022-12-31) — Net Income: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 180000.00
CLST cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 180000.00
CLST income_statement (annual, 2022-12-31) — Net Interest Income: 7331000.00
CLST cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -2323000.00
CLST cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CLST cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CLST cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -9961000.00
CLST balance_sheet (annual, 2022-12-31) — Net PPE: 6303000.00
CLST cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -252000.00
CLST balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 88512000.00
CLST income_statement (annual, 2022-12-31) — Normalized Income: 240830.00
CLST income_statement (annual, 2022-12-31) — Occupancy And Equipment: 833000.00
CLST cash_flow (annual, 2022-12-31) — Operating Cash Flow: 772000.00
CLST cash_flow (annual, 2022-12-31) — Operating Gains Losses: 62000.00
CLST income_statement (annual, 2022-12-31) — Operating Revenue: 8336000.00
CLST balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 5290000.00
CLST balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -9074000.00
CLST balance_sheet (annual, 2022-12-31) — Other Equity Interest: -6307000.00
CLST income_statement (annual, 2022-12-31) — Other Gand A: 143000.00
CLST cash_flow (annual, 2022-12-31) — Other Non Cash Items: 180000.00
CLST income_statement (annual, 2022-12-31) — Other Non Interest Expense: 1605000.00
CLST balance_sheet (annual, 2022-12-31) — Other Properties: 92000.00
CLST balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 79602000.00
CLST income_statement (annual, 2022-12-31) — Other Special Charges: 77000.00
CLST balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CLST income_statement (annual, 2022-12-31) — Pretax Income: 159000.00
CLST cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -2340000.00
CLST income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 538000.00
CLST cash_flow (annual, 2022-12-31) — Purchase Of Investment: -13207000.00
CLST cash_flow (annual, 2022-12-31) — Purchase Of PPE: -252000.00
CLST balance_sheet (annual, 2022-12-31) — Receivables: 673000.00
CLST income_statement (annual, 2022-12-31) — Reconciled Depreciation: 448000.00
CLST cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CLST balance_sheet (annual, 2022-12-31) — Retained Earnings: 52778000.00
CLST income_statement (annual, 2022-12-31) — Salaries And Wages: 5124000.00
CLST cash_flow (annual, 2022-12-31) — Sale Of Investment: 10884000.00
CLST cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CLST income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 240000.00
CLST income_statement (annual, 2022-12-31) — Selling General And Administration: 5499000.00
CLST balance_sheet (annual, 2022-12-31) — Share Issued: 5290000.00
CLST income_statement (annual, 2022-12-31) — Special Income Charges: -77000.00
CLST cash_flow (annual, 2022-12-31) — Stock Based Compensation: 472000.00
CLST balance_sheet (annual, 2022-12-31) — Stockholders Equity: 88512000.00
CLST balance_sheet (annual, 2022-12-31) — Tangible Book Value: 88512000.00
CLST income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -16170.00
CLST income_statement (annual, 2022-12-31) — Tax Provision: -21000.00
CLST income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CLST balance_sheet (annual, 2022-12-31) — Total Assets: 263362000.00
CLST balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 88512000.00
CLST balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 174850000.00
CLST income_statement (annual, 2022-12-31) — Total Unusual Items: -77000.00
CLST income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -77000.00
CLST income_statement (annual, 2023-12-31) — +Total Revenue: 9044000.00
CLST balance_sheet (annual, 2023-12-31) — Accounts Receivable: 906000.00
CLST balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -3818000.00
CLST balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 45020000.00
CLST cash_flow (annual, 2023-12-31) — Amortization Of Securities: 308000.00
CLST cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 66000.00
CLST balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 68897000.00
CLST income_statement (annual, 2023-12-31) — Basic Average Shares: 4300000.00
CLST income_statement (annual, 2023-12-31) — Basic EPS: 0.14
CLST cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13472000.00
CLST balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 6150000.00
CLST cash_flow (annual, 2023-12-31) — Capital Expenditure: -172000.00
CLST balance_sheet (annual, 2023-12-31) — Capital Stock: 48000.00
CLST balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 19011000.00
CLST balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 19011000.00
CLST balance_sheet (annual, 2023-12-31) — Cash Financial: 19011000.00
CLST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 3798000.00
CLST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -267000.00
CLST cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 2008000.00
CLST cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -510000.00
CLST cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 536000.00
CLST cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -409000.00
CLST cash_flow (annual, 2023-12-31) — Change In Working Capital: -383000.00
CLST cash_flow (annual, 2023-12-31) — Changes In Cash: 5539000.00
CLST balance_sheet (annual, 2023-12-31) — Common Stock: 48000.00
CLST balance_sheet (annual, 2023-12-31) — Common Stock Equity: 84559000.00
CLST cash_flow (annual, 2023-12-31) — Common Stock Payments: -6315000.00
CLST cash_flow (annual, 2023-12-31) — Deferred Income Tax: -12000.00
CLST cash_flow (annual, 2023-12-31) — Deferred Tax: -12000.00
CLST cash_flow (annual, 2023-12-31) — Depreciation: 403000.00
CLST cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 403000.00
CLST cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 403000.00
CLST income_statement (annual, 2023-12-31) — Diluted Average Shares: 4300000.00
CLST income_statement (annual, 2023-12-31) — Diluted EPS: 0.14
CLST income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 526000.00
CLST cash_flow (annual, 2023-12-31) — End Cash Position: 19011000.00
CLST cash_flow (annual, 2023-12-31) — Financing Cash Flow: 3798000.00
CLST cash_flow (annual, 2023-12-31) — Free Cash Flow: 1836000.00
CLST cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 92000.00
CLST cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
CLST income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -92000.00
CLST balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -7237000.00
CLST income_statement (annual, 2023-12-31) — General And Administrative Expense: 5240000.00
CLST balance_sheet (annual, 2023-12-31) — Gross PPE: 9890000.00
CLST balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 13461000.00
CLST cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
CLST income_statement (annual, 2023-12-31) — Insurance And Claims: 106000.00
CLST income_statement (annual, 2023-12-31) — Interest Expense: 1956000.00
CLST income_statement (annual, 2023-12-31) — Interest Income: 9661000.00
CLST cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 1402000.00
CLST balance_sheet (annual, 2023-12-31) — Invested Capital: 93937000.00
CLST cash_flow (annual, 2023-12-31) — Investing Cash Flow: -267000.00
CLST balance_sheet (annual, 2023-12-31) — Investments And Advances: 84001000.00
CLST cash_flow (annual, 2023-12-31) — Issuance Of Debt: 10000000.00
CLST balance_sheet (annual, 2023-12-31) — Land And Improvements: 1767000.00
CLST balance_sheet (annual, 2023-12-31) — Long Term Debt: 9378000.00
CLST balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 9378000.00
CLST cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 10000000.00
CLST balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1881000.00
CLST cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -6315000.00
CLST income_statement (annual, 2023-12-31) — Net Income: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 526000.00
CLST cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 526000.00
CLST income_statement (annual, 2023-12-31) — Net Interest Income: 7705000.00
CLST cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 11001000.00
CLST cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 10000000.00
CLST cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 10000000.00
CLST cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 320000.00
CLST balance_sheet (annual, 2023-12-31) — Net PPE: 6072000.00
CLST cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -172000.00
CLST balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 84559000.00
CLST income_statement (annual, 2023-12-31) — Normalized Income: 526000.00
CLST income_statement (annual, 2023-12-31) — Occupancy And Equipment: 802000.00
CLST cash_flow (annual, 2023-12-31) — Operating Cash Flow: 2008000.00
CLST cash_flow (annual, 2023-12-31) — Operating Gains Losses: 23000.00
CLST income_statement (annual, 2023-12-31) — Operating Revenue: 9044000.00
CLST balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 4761326.00
CLST balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -7237000.00
CLST balance_sheet (annual, 2023-12-31) — Other Equity Interest: -6221000.00
CLST income_statement (annual, 2023-12-31) — Other Gand A: 145000.00
CLST cash_flow (annual, 2023-12-31) — Other Non Cash Items: 180000.00
CLST income_statement (annual, 2023-12-31) — Other Non Interest Expense: 1701000.00
CLST balance_sheet (annual, 2023-12-31) — Other Properties: 92000.00
CLST balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1643000.00
CLST balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CLST income_statement (annual, 2023-12-31) — Pretax Income: 587000.00
CLST cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: -415000.00
CLST income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 486000.00
CLST cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CLST cash_flow (annual, 2023-12-31) — Purchase Of PPE: -172000.00
CLST balance_sheet (annual, 2023-12-31) — Receivables: 906000.00
CLST income_statement (annual, 2023-12-31) — Reconciled Depreciation: 403000.00
CLST cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -6315000.00
CLST balance_sheet (annual, 2023-12-31) — Retained Earnings: 52949000.00
CLST income_statement (annual, 2023-12-31) — Salaries And Wages: 5134000.00
CLST cash_flow (annual, 2023-12-31) — Sale Of Investment: 11001000.00
CLST cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CLST income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 100000.00
CLST income_statement (annual, 2023-12-31) — Selling General And Administration: 5340000.00
CLST balance_sheet (annual, 2023-12-31) — Share Issued: 4761326.00
CLST income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CLST cash_flow (annual, 2023-12-31) — Stock Based Compensation: 769000.00
CLST balance_sheet (annual, 2023-12-31) — Stockholders Equity: 84559000.00
CLST balance_sheet (annual, 2023-12-31) — Tangible Book Value: 84559000.00
CLST income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLST income_statement (annual, 2023-12-31) — Tax Provision: 61000.00
CLST income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.10
CLST balance_sheet (annual, 2023-12-31) — Total Assets: 270932000.00
CLST balance_sheet (annual, 2023-12-31) — Total Capitalization: 93937000.00
CLST balance_sheet (annual, 2023-12-31) — Total Debt: 9378000.00
CLST balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 84559000.00
CLST balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 186373000.00
CLST income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CLST income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CLST balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CLST income_statement (quarterly, 2024-09-30) — Insurance And Claims: 26000.00
CLST cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 0.00
CLST income_statement (annual, 2024-12-31) — +Total Revenue: 5558000.00
CLST balance_sheet (annual, 2024-12-31) — Accounts Receivable: 851000.00
CLST balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4078000.00
CLST balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -4078000.00
CLST balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 39561000.00
CLST cash_flow (annual, 2024-12-31) — Amortization Of Securities: 140000.00
CLST cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 57000.00
CLST balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 28712000.00
CLST balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 28712000.00
CLST income_statement (annual, 2024-12-31) — Basic Average Shares: 3960256.00
CLST income_statement (annual, 2024-12-31) — Basic EPS: -0.78
CLST cash_flow (annual, 2024-12-31) — Beginning Cash Position: 19011000.00
CLST balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 6196000.00
CLST balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 6196000.00
CLST cash_flow (annual, 2024-12-31) — Capital Expenditure: -430000.00
CLST balance_sheet (annual, 2024-12-31) — Capital Stock: 43000.00
CLST balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 44295000.00
CLST balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 44295000.00
CLST balance_sheet (annual, 2024-12-31) — Cash Financial: 44295000.00
CLST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 4295000.00
CLST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 17817000.00
CLST cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3172000.00
CLST cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 44000.00
CLST cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 24000.00
CLST cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -463000.00
CLST cash_flow (annual, 2024-12-31) — Change In Working Capital: -395000.00
CLST cash_flow (annual, 2024-12-31) — Changes In Cash: 25284000.00
CLST balance_sheet (annual, 2024-12-31) — Common Stock: 43000.00
CLST balance_sheet (annual, 2024-12-31) — Common Stock Equity: 80204000.00
CLST cash_flow (annual, 2024-12-31) — Common Stock Payments: -5757000.00
CLST cash_flow (annual, 2024-12-31) — Deferred Income Tax: -894000.00
CLST cash_flow (annual, 2024-12-31) — Deferred Tax: -894000.00
CLST cash_flow (annual, 2024-12-31) — Depreciation: 412000.00
CLST cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 412000.00
CLST cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 412000.00
CLST income_statement (annual, 2024-12-31) — Diluted Average Shares: 3960256.00
CLST income_statement (annual, 2024-12-31) — Diluted EPS: -0.78
CLST income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3089000.00
CLST cash_flow (annual, 2024-12-31) — End Cash Position: 44295000.00
CLST cash_flow (annual, 2024-12-31) — Financing Cash Flow: 4295000.00
CLST cash_flow (annual, 2024-12-31) — Free Cash Flow: 2742000.00
CLST cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 5507000.00
CLST cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -6000.00
CLST cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CLST income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -5507000.00
CLST income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
CLST balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3558000.00
CLST income_statement (annual, 2024-12-31) — General And Administrative Expense: 5291000.00
CLST balance_sheet (annual, 2024-12-31) — Gross PPE: 10163000.00
CLST balance_sheet (quarterly, 2024-12-31) — Gross PPE: 10163000.00
CLST balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 13447000.00
CLST cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 200000.00
CLST cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
CLST income_statement (annual, 2024-12-31) — Insurance And Claims: 103000.00
CLST income_statement (quarterly, 2024-12-31) — Insurance And Claims: 26000.00
CLST income_statement (annual, 2024-12-31) — Interest Expense: 4317000.00
CLST income_statement (annual, 2024-12-31) — Interest Income: 13862000.00
CLST cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 4287000.00
CLST balance_sheet (annual, 2024-12-31) — Invested Capital: 89762000.00
CLST cash_flow (annual, 2024-12-31) — Investing Cash Flow: 17817000.00
CLST balance_sheet (annual, 2024-12-31) — Investments And Advances: 42159000.00
CLST cash_flow (annual, 2024-12-31) — Issuance Of Debt: 793000.00
CLST balance_sheet (annual, 2024-12-31) — Land And Improvements: 1767000.00
CLST balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1767000.00
CLST balance_sheet (annual, 2024-12-31) — Long Term Debt: 9558000.00
CLST balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 9558000.00
CLST cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 793000.00
CLST cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -793000.00
CLST balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2100000.00
CLST balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2100000.00
CLST cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -5757000.00
CLST income_statement (annual, 2024-12-31) — Net Income: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3089000.00
CLST cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3089000.00
CLST income_statement (annual, 2024-12-31) — Net Interest Income: 9545000.00
CLST cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 40852000.00
CLST cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CLST cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CLST cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 114000.00
CLST balance_sheet (annual, 2024-12-31) — Net PPE: 6085000.00
CLST cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -418000.00
CLST balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 80204000.00
CLST income_statement (annual, 2024-12-31) — Normalized Income: -3093656.00
CLST income_statement (annual, 2024-12-31) — Occupancy And Equipment: 765000.00
CLST cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3172000.00
CLST cash_flow (annual, 2024-12-31) — Operating Gains Losses: 5418000.00
CLST income_statement (annual, 2024-12-31) — Operating Revenue: 5558000.00
CLST balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4278150.00
CLST balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -3558000.00
CLST balance_sheet (annual, 2024-12-31) — Other Equity Interest: -5702000.00
CLST income_statement (annual, 2024-12-31) — Other Gand A: 87000.00
CLST cash_flow (annual, 2024-12-31) — Other Non Cash Items: 180000.00
CLST income_statement (annual, 2024-12-31) — Other Non Interest Expense: 2362000.00
CLST balance_sheet (annual, 2024-12-31) — Other Properties: 100000.00
CLST balance_sheet (quarterly, 2024-12-31) — Other Properties: 100000.00
CLST balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 28712000.00
CLST income_statement (annual, 2024-12-31) — Other Special Charges: -6000.00
CLST income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CLST balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CLST income_statement (annual, 2024-12-31) — Pretax Income: -3983000.00
CLST cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CLST cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
CLST income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 469000.00
CLST cash_flow (annual, 2024-12-31) — Purchase Of Investment: -7873000.00
CLST cash_flow (annual, 2024-12-31) — Purchase Of PPE: -430000.00
CLST balance_sheet (annual, 2024-12-31) — Receivables: 851000.00
CLST income_statement (annual, 2024-12-31) — Reconciled Depreciation: 412000.00
CLST cash_flow (annual, 2024-12-31) — Repayment Of Debt: -793000.00
CLST cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -5757000.00
CLST balance_sheet (annual, 2024-12-31) — Retained Earnings: 49860000.00
CLST income_statement (annual, 2024-12-31) — Salaries And Wages: 5291000.00
CLST cash_flow (annual, 2024-12-31) — Sale Of Investment: 48725000.00
CLST cash_flow (annual, 2024-12-31) — Sale Of PPE: 12000.00
CLST cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
CLST income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 129000.00
CLST income_statement (annual, 2024-12-31) — Selling General And Administration: 5420000.00
CLST balance_sheet (annual, 2024-12-31) — Share Issued: 4278150.00
CLST income_statement (annual, 2024-12-31) — Special Income Charges: 6000.00
CLST income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CLST cash_flow (annual, 2024-12-31) — Stock Based Compensation: 812000.00
CLST balance_sheet (annual, 2024-12-31) — Stockholders Equity: 80204000.00
CLST balance_sheet (annual, 2024-12-31) — Tangible Book Value: 80204000.00
CLST income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1344.00
CLST income_statement (annual, 2024-12-31) — Tax Provision: -894000.00
CLST income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
CLST balance_sheet (annual, 2024-12-31) — Total Assets: 276697000.00
CLST balance_sheet (annual, 2024-12-31) — Total Capitalization: 89762000.00
CLST balance_sheet (annual, 2024-12-31) — Total Debt: 9558000.00
CLST balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 80204000.00
CLST balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 196493000.00
CLST income_statement (annual, 2024-12-31) — Total Unusual Items: 6000.00
CLST income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CLST income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6000.00
CLST income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CLST income_statement (quarterly, 2025-03-31) — +Total Revenue: 2702000.00
CLST balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 866000.00
CLST balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 38844000.00
CLST cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 19000.00
CLST cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 88000.00
CLST balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1509000.00
CLST income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3662500.00
CLST income_statement (quarterly, 2025-03-31) — Basic EPS: 0.16
CLST cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 44295000.00
CLST cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -66000.00
CLST balance_sheet (quarterly, 2025-03-31) — Capital Stock: 42000.00
CLST balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 40318000.00
CLST balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 40318000.00
CLST balance_sheet (quarterly, 2025-03-31) — Cash Financial: 40318000.00
CLST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -5942000.00
CLST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1538000.00
CLST cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 427000.00
CLST cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -161000.00
CLST cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -388000.00
CLST cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -118000.00
CLST cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -667000.00
CLST cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3977000.00
CLST balance_sheet (quarterly, 2025-03-31) — Common Stock: 42000.00
CLST balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 80591000.00
CLST cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -866000.00
CLST cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 71000.00
CLST cash_flow (quarterly, 2025-03-31) — Deferred Tax: 71000.00
CLST cash_flow (quarterly, 2025-03-31) — Depreciation: 103000.00
CLST cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 103000.00
CLST cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 103000.00
CLST income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3662500.00
CLST income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.16
CLST income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 586000.00
CLST cash_flow (quarterly, 2025-03-31) — End Cash Position: 40318000.00
CLST cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -5942000.00
CLST cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 361000.00
CLST cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CLST income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 0.00
CLST balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -3092000.00
CLST income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1359000.00
CLST balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 13445000.00
CLST cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CLST income_statement (quarterly, 2025-03-31) — Interest Expense: 1009000.00
CLST income_statement (quarterly, 2025-03-31) — Interest Income: 3374000.00
CLST cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 1013000.00
CLST balance_sheet (quarterly, 2025-03-31) — Invested Capital: 90194000.00
CLST cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 1538000.00
CLST balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 43285000.00
CLST cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CLST balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 9603000.00
CLST balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 9603000.00
CLST cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -866000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 586000.00
CLST cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Net Interest Income: 2365000.00
CLST cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -556000.00
CLST cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 1200000.00
CLST balance_sheet (quarterly, 2025-03-31) — Net PPE: 6049000.00
CLST cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -66000.00
CLST balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 80591000.00
CLST income_statement (quarterly, 2025-03-31) — Normalized Income: 586000.00
CLST income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 199000.00
CLST cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 427000.00
CLST cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -19000.00
CLST income_statement (quarterly, 2025-03-31) — Operating Revenue: 2702000.00
CLST balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4205201.00
CLST balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -3092000.00
CLST balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -5649000.00
CLST cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 45000.00
CLST income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 284000.00
CLST balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 28331000.00
CLST balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CLST income_statement (quarterly, 2025-03-31) — Pretax Income: 720000.00
CLST income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 101000.00
CLST cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1266000.00
CLST cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -66000.00
CLST balance_sheet (quarterly, 2025-03-31) — Receivables: 866000.00
CLST income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 103000.00
CLST cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -866000.00
CLST balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 50446000.00
CLST income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1359000.00
CLST cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 710000.00
CLST cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
CLST income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 39000.00
CLST income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1398000.00
CLST balance_sheet (quarterly, 2025-03-31) — Share Issued: 4205201.00
CLST income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CLST cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 201000.00
CLST balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 80591000.00
CLST balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 80591000.00
CLST income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLST income_statement (quarterly, 2025-03-31) — Tax Provision: 134000.00
CLST income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
CLST balance_sheet (quarterly, 2025-03-31) — Total Assets: 271648000.00
CLST balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 90194000.00
CLST balance_sheet (quarterly, 2025-03-31) — Total Debt: 9603000.00
CLST balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 80591000.00
CLST balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 191057000.00
CLST income_statement (quarterly, 2025-03-31) — Total Unusual Items: 216000.00
CLST income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 216000.00
CLST income_statement (quarterly, 2025-06-30) — +Total Revenue: 2783000.00
CLST balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 883000.00
CLST balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 38259000.00
CLST cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 22000.00
CLST cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 14000.00
CLST income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3721429.00
CLST income_statement (quarterly, 2025-06-30) — Basic EPS: 0.14
CLST cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 40318000.00
CLST cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -34000.00
CLST balance_sheet (quarterly, 2025-06-30) — Capital Stock: 41000.00
CLST balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 40056000.00
CLST balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 40056000.00
CLST balance_sheet (quarterly, 2025-06-30) — Cash Financial: 40056000.00
CLST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 871000.00
CLST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2284000.00
CLST cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 1151000.00
CLST cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 40000.00
CLST cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 245000.00
CLST cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -119000.00
CLST cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 166000.00
CLST cash_flow (quarterly, 2025-06-30) — Changes In Cash: -262000.00
CLST balance_sheet (quarterly, 2025-06-30) — Common Stock: 41000.00
CLST balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 80799000.00
CLST cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -742000.00
CLST cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 86000.00
CLST cash_flow (quarterly, 2025-06-30) — Deferred Tax: 86000.00
CLST cash_flow (quarterly, 2025-06-30) — Depreciation: 105000.00
CLST cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 105000.00
CLST cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 105000.00
CLST income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3721429.00
CLST income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.14
CLST income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 521000.00
CLST cash_flow (quarterly, 2025-06-30) — End Cash Position: 40056000.00
CLST cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 871000.00
CLST cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1117000.00
CLST cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
CLST income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 0.00
CLST balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2872000.00
CLST income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1379000.00
CLST balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 14948000.00
CLST cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 39000.00
CLST income_statement (quarterly, 2025-06-30) — Interest Expense: 993000.00
CLST income_statement (quarterly, 2025-06-30) — Interest Income: 3461000.00
CLST cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 956000.00
CLST balance_sheet (quarterly, 2025-06-30) — Invested Capital: 90446000.00
CLST cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2284000.00
CLST balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 44242000.00
CLST cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CLST balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 9647000.00
CLST balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 9647000.00
CLST cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CLST cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -742000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 521000.00
CLST cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Net Interest Income: 2468000.00
CLST cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -699000.00
CLST cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CLST cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 0.00
CLST cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
CLST balance_sheet (quarterly, 2025-06-30) — Net PPE: 5977000.00
CLST cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -34000.00
CLST balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 80799000.00
CLST income_statement (quarterly, 2025-06-30) — Normalized Income: 521000.00
CLST income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 208000.00
CLST cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 1151000.00
CLST cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -17000.00
CLST income_statement (quarterly, 2025-06-30) — Operating Revenue: 2783000.00
CLST balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4142816.00
CLST balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2872000.00
CLST balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -5596000.00
CLST cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 45000.00
CLST income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 428000.00
CLST balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 29294000.00
CLST balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CLST income_statement (quarterly, 2025-06-30) — Pretax Income: 634000.00
CLST income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 114000.00
CLST cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1506000.00
CLST cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -34000.00
CLST balance_sheet (quarterly, 2025-06-30) — Receivables: 883000.00
CLST income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 105000.00
CLST cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -742000.00
CLST balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 50967000.00
CLST income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1379000.00
CLST cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 807000.00
CLST cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CLST income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 20000.00
CLST income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1399000.00
CLST balance_sheet (quarterly, 2025-06-30) — Share Issued: 4142816.00
CLST income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CLST cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 209000.00
CLST balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 80799000.00
CLST balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 80799000.00
CLST income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLST income_statement (quarterly, 2025-06-30) — Tax Provision: 113000.00
CLST income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.18
CLST balance_sheet (quarterly, 2025-06-30) — Total Assets: 273785000.00
CLST balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 90446000.00
CLST balance_sheet (quarterly, 2025-06-30) — Total Debt: 9647000.00
CLST balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 80799000.00
CLST balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 192986000.00
CLST income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CLST income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CLST income_statement (quarterly, 2025-09-30) — +Total Revenue: 2742000.00
CLST balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 861000.00
CLST balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 37997000.00
CLST cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 19000.00
CLST cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 4000.00
CLST income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3761538.00
CLST income_statement (quarterly, 2025-09-30) — Basic EPS: 0.13
CLST cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 40056000.00
CLST cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -85000.00
CLST balance_sheet (quarterly, 2025-09-30) — Capital Stock: 41000.00
CLST balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 37271000.00
CLST balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 37271000.00
CLST balance_sheet (quarterly, 2025-09-30) — Cash Financial: 37271000.00
CLST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 8990000.00
CLST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -12687000.00
CLST cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 912000.00
CLST cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 14000.00
CLST cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 67000.00
CLST cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -123000.00
CLST cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -42000.00
CLST cash_flow (quarterly, 2025-09-30) — Changes In Cash: -2785000.00
CLST balance_sheet (quarterly, 2025-09-30) — Common Stock: 41000.00
CLST balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 81585000.00
CLST cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -171000.00
CLST cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 91000.00
CLST cash_flow (quarterly, 2025-09-30) — Deferred Tax: 91000.00
CLST cash_flow (quarterly, 2025-09-30) — Depreciation: 107000.00
CLST cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 107000.00
CLST cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 107000.00
CLST income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3761538.00
CLST income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.13
CLST income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 489000.00
CLST cash_flow (quarterly, 2025-09-30) — End Cash Position: 37271000.00
CLST cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 8990000.00
CLST cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 827000.00
CLST cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
CLST cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 1000.00
CLST income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 0.00
CLST balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2649000.00
CLST income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1435000.00
CLST balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 14945000.00
CLST cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 27000.00
CLST income_statement (quarterly, 2025-09-30) — Interest Expense: 1063000.00
CLST income_statement (quarterly, 2025-09-30) — Interest Income: 3513000.00
CLST cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 981000.00
CLST balance_sheet (quarterly, 2025-09-30) — Invested Capital: 96278000.00
CLST cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -12687000.00
CLST balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 59798000.00